By Paulo Rangel President & CEO of Evince Biosciences, Inc. Evince Biosciences is a next generation drug discovery company, using a compelling machine learning approach to reimagining drug discovery. Our first program targets toll-like receptor 7 (TLR7) for cancer immunotherapy. Simply stated, without a dramatic increase in R&D productivity, today’s pharmaceutical industry cannot sustain sufficient … Continue reading Combining an Unparalleled AI Platform with a Seasoned Pharma Team, Evince Biosciences Reimagines Drug Discovery and takes on Cancer Immunotherapy
The Festival of Genomics San Diego (June 26-27, 2017) will bring together the genomics community with the collaborative goal to drive the benefits of genomics to patients, faster. The Festival will provide the big picture of what is going on within the industry. If you’re using genomics to drive forward R&D, drug development or the … Continue reading Festival of Genomics San Diego
We are excited to announce that earlier this month several CLSA member companies, in conjunction with CLSA, CLSI and KNBR, launched the “Giants of Science” competition in San Francisco to award three $20,000 science program grants to Bay Area high schools who submit an application and video explaining why they need the grant and what … Continue reading CLSA Announces Bay Area “Giants of Sciences” Partnership with KNBR to Support Life Sciences Education
Join Oracle & CLSA for Happy Hour with the best of Bay Area’s life sciences community at Foundry & Lux.
Join Oracle & CLSA for Happy Hour with the best of San Diego’s life sciences community at Green Acre Campus Pointe
Going public was an appealing option as recently as three years ago. In 2014, total U.S. IPOs reached one of the market’s highest points, with 273 companies making their initial public offering. Biotech companies made up nearly 25 percent of total public offerings according to research compiled by Renaissance Capital. IPOs in 2015, however, failed … Continue reading How the IPO Environment Affects BioTech Growth
By Eric Tulin & Amy Conrad Science buffs, biotechnology advisors and San Diego aficionados BIO is BIG 4,000+ attending companies 1,800+ exhibiting companies 2,500 CEOs 16,000+ attendees from 76 countries BIO is a BIG Opportunity to Tell Your Story If you are attending or exhibiting and networking with potential buyers, investors, partners, employers and talent, … Continue reading The BIO International Convention is Coming to San Diego in June – Tips, Tricks and How to Maximize Your Time at #BIO2017
With 17 propositions on California’s November ballot, there is one that stands out as particularly bad for patients, veterans and taxpayers: Proposition 61.
Fast-growing Marketing and PR Firm Evolves Brand to Better Reflect Agency Culture, Focus on Converging Healthcare and Life Science Markets CHICAGO & SAN DIEGO & BOSTON–(BUSINESS WIRE)–Chempetitive Group, an integrated marketing communications agency focused on life science and healthcare, has unveiled a new brand and name. The new name CG Life, and new tagline Do … Continue reading Chempetitive Group Rebrands as CG Life